OOIR: Observatory of International Research

Papers

(The TQCC of Progress in Retinal and Eye Research is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective	252
Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration	239
The cell biology of the retinal pigment epithelium	188
Inflammation in Glaucoma: From the back to the front of the eye, and beyond	179
Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations	171
Exploring choroidal angioarchitecture in health and disease using choroidal vascularity index	143
Retinal applications of swept source optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA)	135
Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities	130
Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders	129
Efficacy in myopia control	125
Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives	123
VEGFR1 signaling in retinal angiogenesis and microinflammation	123
Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities	123
Age-related macular degeneration: A two-level model hypothesis	102
Immune responses to retinal gene therapy using adeno-associated viral vectors – Implications for treatment success and safety	102
Activation of the interleukin-23/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis	101
Cell types and cell circuits in human and non-human primate retina	97
Interactions of the choroid, Bruch's membrane, retinal pigment epithelium, and neurosensory retina collaborate to form the outer blood-retinal-barrier	84
Fuchs endothelial corneal dystrophy: The vicious cycle of Fuchs pathogenesis	84
Corneal endothelial dysfunction: Evolving understanding and treatment options	83
Advances in the diagnosis and treatment of dry eye	82
Early and late stage gene therapy interventions for inherited retinal degenerations	82
Photoreceptor cells and RPE contribute to the development of diabetic retinopathy	82
Paracentral acute middle maculopathy and the organization of the retinal capillary plexuses	79
Posterior capsule opacification: What's in the bag?	77

Optic nerve head anatomy in myopia and glaucoma, including parapapillary zones alpha, beta, gamma and delta: Histology and clinical features	77
Normal and glaucomatous outflow regulation	73
Retina in a dish: Cell cultures, retinal explants and animal models for common diseases of the retina	70
Contact lens-related corneal infection: Intrinsic resistance and its compromise	70
Interpretation of OCT and OCTA images from a histological approach: Clinical and experimental implications	69
Extracellular vesicle therapy for retinal diseases	66
Retinal changes in Alzheimer's disease— integrated prospects of imaging, functional and molecular advances	65
Plexus-specific retinal vascular anatomy and pathologies as seen by projection-resolved optical coherence tomographic angiography	65
The X-linked retinopathies: Physiological insights, pathogenic mechanisms, phenotypic features and novel therapies	64
Past, present and future role of retinal imaging in neurodegenerative disease	59
Inherited retinal diseases: Linking genes, disease-causing variants, and relevant therapeutic modalities	58
Choriocapillaris: Fundamentals and advancements	57
Adaptive responses to neurodegenerative stress in glaucoma	56
Sustained suppression of VEGF for treatment of retinal/choroidal vascular diseases	55
Artificial intelligence in OCT angiography	54
Molecular regulation of neuroinflammation in glaucoma: Current knowledge and the ongoing search for new treatment targets	54
Fundus autofluorescence imaging	52
Discovery and clinical translation of novel glaucoma biomarkers	50
Uncoupling proteins in the mitochondrial defense against oxidative stress	50
Fundus-controlled perimetry (microperimetry): Application as outcome measure in clinical trials	50
Critical analysis of techniques and materials used in devices, syringes, and needles used for intravitreal injections	50
Retinal energy metabolism in health and glaucoma	50
Reticular pseudodrusen: A critical phenotype in age-related macular degeneration	50
Regenerative therapy for the Cornea	49
Human limbal epithelial stem cell regulation, bioengineering and function	49
Corneal stromal repair and regeneration	49
The vital role for nitric oxide in intraocular pressure homeostasis	48
The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas	48
Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma	47
Dominant optic atrophy: Culprit mitochondria in the optic nerve	47
Vitreous and Vision Degrading Myodesopsia	47
The innate immune system in diabetic retinopathy	44
Ocular blood flow as a clinical observation: Value, limitations and data analysis	43
Pathogenesis of ocular toxoplasmosis	42